Wellness companies eager to avoid WeightWatchers' fate embrace weight-loss drugs
Wellness companies eager to avoid WeightWatchers' fate embrace weight-loss drugs
Related Posts
Federal Reserve will likely slow its rate cuts in 2025 as inflation stays stubbornly high
Some economists question whether the Fed even needs to cut this week. Inflation, excluding volatile food and energy costs, has…
How to get from the me to the we society
The writer, an FT contributing editor, is chief executive of the Royal Society of Arts and former chief economist at the…
Russia stocks lower at close of trade; MOEX Russia Index unchanged
Russia stocks lower at close of trade; MOEX Russia Index unchanged